Glenmark receives ANDA approval for Clobetasol Propionate Foam EP News Bureau Sep 10, 2019 The drug is indicated for the treatment of plaque psoriasis Glenmark Pharmaceuticals, USA (Glenmark) has been granted final…
Novartis Cosentyx’s first IL-17 inhibitor to receive EU approval Usha Sharma Jan 19, 2015 Cosentyx is the only biologic that can be used as first-line systemic therapy in the treatment of psoriasis and as an alternative…
